For example, in the study investigating the sensitivity of immunohistochemistry (IHC) versus Sanger sequencing to BRAF V600E mutations in FFPE derived DNA from papillary thyroid carcinoma specimens, Bullock and colleagues utilised the TSACP as an alternative sequencing platform[23]. This evidence concerns the gene BRAF and differentiated thyroid carcinoma.